Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
12°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Landec Cp
(NQ:
LNDC
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 14, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
8.250 (1)
Ask (Size)
8.930 (20)
Prev. Close
8.760
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
29,456,705
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
April 30, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
April 20, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Performance
More News
Read More
ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
April 11, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
Lifecore Biomedical Announces Completion of Corporate Name Change
November 14, 2022
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical to Participate in the Stephens Annual Investment Conference on Thursday, November 17, 2022
November 10, 2022
From
Landec Corporation
Via
GlobeNewswire
Landec Expects to Change Corporate Name to Lifecore Biomedical and Ticker Symbol to “LFCR” on November 14
November 01, 2022
From
Landec Corporation
Via
GlobeNewswire
Landec: Q1 Earnings Insights
October 06, 2022
Via
Benzinga
Landec Corporation Reports First Quarter Fiscal Year 2023 Results
October 06, 2022
From
Landec Corporation
Via
GlobeNewswire
Earnings Scheduled For October 6, 2022
October 06, 2022
Via
Benzinga
A Preview Of Landec's Earnings
October 05, 2022
Via
Benzinga
Landec Corporation Revises First Quarter 2023 Earnings Conference Call for October 6, 2022 at 8:00 a.m. ET
September 28, 2022
From
Landec Corporation
Via
GlobeNewswire
7 Small-Cap Stocks to Buy Before September Ends
September 14, 2022
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2022
August 11, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
July 20, 2022
Via
Benzinga
Earnings Scheduled For April 5, 2022
April 05, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
April 06, 2022
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Drops 150 Points; Quidel Shares Spike Higher
February 18, 2022
Via
Benzinga
3 Stocks Insiders Are Buying
January 18, 2022
Via
Benzinga
A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Economic Data
January 06, 2022
Via
Benzinga
5 Stocks To Watch For January 6, 2022
January 06, 2022
Via
Benzinga
Landec: Q2 Earnings Insights
January 05, 2022
Via
Benzinga
Earnings Scheduled For January 5, 2022
January 05, 2022
Via
Benzinga
Earnings Outlook For Landec
January 04, 2022
Via
Benzinga
50 Biggest Movers From Yesterday
December 15, 2021
Via
Benzinga
Mid-Afternoon Market Update: Dow Falls 100 Points; Terminix Shares Spike Higher
December 14, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.